MEDA: Interim Report, January-March 2016
Central Garden & Pet Company to Announce Second Quarter Fiscal 2016 Financial Results
China Eases Path for Foreign Drugmakers' Hepatitis C Treatments
J&J Makes Push For African Sales -- WSJ
J&J Makes Renewed Push Into Africa
IMS Health is on the right track for growth.
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
Regulatory issues that we believe have little impact on Novo Nordisk's long-run prospects have finally helped shares of the leading insulin maker go on sale.